Role of apoptosis in the development of autosomal dominant polycystic kidney disease (ADPKD)

[1]  E. Dueber,et al.  Recent Insights into the Molecular Mechanisms Underlying Pyroptosis and Gasdermin Family Functions. , 2017, Trends in immunology.

[2]  Juan R. Cubillos-Ruiz,et al.  Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer , 2017, Cell.

[3]  L. Guay-Woodford,et al.  Polycystic kidney disease , 2017, Nature Reviews Disease Primers.

[4]  S. Stilgenbauer,et al.  Venetoclax in Patients with Previously Treated Chronic Lymphocytic Leukemia , 2017, Clinical Cancer Research.

[5]  D. Green,et al.  Necroptosis in development, inflammation and disease , 2016, Nature Reviews Molecular Cell Biology.

[6]  Junying Yuan,et al.  Roles of Caspases in Necrotic Cell Death , 2016, Cell.

[7]  R. Hua,et al.  Autophagy in long propriospinal neurons is activated after spinal cord injury in adult rats , 2016, Neuroscience Letters.

[8]  A. Strasser,et al.  The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models , 2016, Nature.

[9]  C. Borner,et al.  SPATA2 promotes CYLD activity and regulates TNF‐induced NF‐κB signaling and cell death , 2016, EMBO reports.

[10]  J. Parys,et al.  Intracellular Ca(2+) signaling and Ca(2+) microdomains in the control of cell survival, apoptosis and autophagy. , 2016, Cell calcium.

[11]  C. Muñoz-Pinedo,et al.  Cell death induced by endoplasmic reticulum stress , 2016, The FEBS journal.

[12]  J. Silke,et al.  Killing Lymphoma with Smac-Mimetics: As Easy as ABC? , 2016, Cancer Cell.

[13]  D. Green,et al.  Developmental checkpoints guarded by regulated necrosis , 2016, Cellular and Molecular Life Sciences.

[14]  A. Letai,et al.  Mitochondria-Judges and Executioners of Cell Death Sentences. , 2016, Molecular cell.

[15]  S. Somlo,et al.  mTORC1-mediated inhibition of polycystin-1 expression drives renal cyst formation in tuberous sclerosis complex , 2016, Nature Communications.

[16]  D. Clapham,et al.  Primary Cilia Are Not Calcium-Responsive Mechanosensors , 2016, Nature.

[17]  Youhua Liu,et al.  Wnt/β-catenin signaling in kidney injury and repair: a double-edged sword , 2015, Laboratory Investigation.

[18]  M. Trudel.  c-Myc Signalling in the Genetic Mechanism of Polycystic Kidney Disease , 2015 .

[19]  S. Fulda.  Promises and Challenges of Smac Mimetics as Cancer Therapeutics , 2015, Clinical Cancer Research.

[20]  J. Spatz,et al.  Bax monomers form dimer units in the membrane that further self-assemble into multiple oligomeric species , 2015, Nature Communications.

[21]  Christopher R Jacobs,et al.  The primary cilium functions as a mechanical and calcium signaling nexus , 2015, Cilia.

[22]  S. Somlo,et al.  Sec63 and Xbp1 regulate IRE1α activity and polycystic disease severity. , 2015, The Journal of clinical investigation.

[23]  S. Geley,et al.  The NOXA–MCL1–BIM axis defines lifespan on extended mitotic arrest , 2015, Nature Communications.

[24]  A. Villunger,et al.  The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd , 2015, Cell Death and Differentiation.

[25]  Kyung Lee,et al.  Inactivation of integrin-β1 prevents the development of polycystic kidney disease after the loss of polycystin-1. , 2015, Journal of the American Society of Nephrology : JASN.

[26]  W. Gu,et al.  Ferroptosis as a p53-mediated activity during tumour suppression , 2015, Nature.

[27]  J. Bonventre,et al.  Polycystin-1 and Gα12 regulate the cleavage of E-cadherin in kidney epithelial cells. , 2015, Physiological Genomics.

[28]  P. Vandenabeele,et al.  Necroptosis and its role in inflammation , 2015, Nature.

[29]  G. Dewson.  Two roads to death – Bax targets mitochondria by distinct routes before or during apoptotic cell death , 2015, Molecular & cellular oncology.

[30]  S. Somlo,et al.  Altered trafficking and stability of polycystins underlie polycystic kidney disease. , 2014, The Journal of clinical investigation.

[31]  D. Peters,et al.  Translational research in ADPKD: lessons from animal models , 2014, Nature Reviews Nephrology.

[32]  A. Ong,et al.  How simple are 'simple renal cysts'? , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  A. Takakura,et al.  Polycystin-1 regulates actin cytoskeleton organization and directional cell migration through a novel PC1-Pacsin 2-N-Wasp complex. , 2014, Human molecular genetics.

[34]  S. Nauli,et al.  The Roles of Primary cilia in Polycystic Kidney Disease , 2013, AIMS molecular science.

[35]  E. Avner,et al.  Smac-mimetic-induced epithelial cell death reduces the growth of renal cysts. , 2013, Journal of the American Society of Nephrology : JASN.

[36]  Paola Chiarugi,et al.  Anoikis molecular pathways and its role in cancer progression. , 2013, Biochimica et biophysica acta.

[37]  G. Häcker,et al.  Roscovitine-induced Apoptosis in Neutrophils and Neutrophil Progenitors Is Regulated by the Bcl-2-Family Members Bim, Puma, Noxa and Mcl-1 , 2013, PloS one.

[38]  C. Borner,et al.  Apoptosis induced by the fungal pathogen gliotoxin requires a triple phosphorylation of Bim by JNK , 2013, Cell Death and Differentiation.

[39]  N. Waterhouse,et al.  Flow cytometry based assays for the measurement of apoptosis-associated mitochondrial membrane depolarisation and cytochrome c release. , 2013, Methods.

[40]  A. Boletta,et al.  Defective Glucose Metabolism in Polycystic Kidney Disease Identifies A Novel Therapeutic Paradigm , 2016 .

[41]  P. Rabinovitch,et al.  mTOR is a key modulator of ageing and age-related disease , 2013, Nature.

[42]  Vladimir G. Gainullin,et al.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. , 2012, The Journal of clinical investigation.

[43]  M. MacFarlane,et al.  The 'complexities' of life and death: death receptor signalling platforms. , 2012, Experimental cell research.

[44]  M. R. Lamprecht,et al.  Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death , 2012, Cell.

[45]  V. de Laurenzi,et al.  Role of Apoptosis in disease , 2012, Aging.

[46]  R. Peyronnet,et al.  Mechanoprotection by Polycystins Against Apoptosis is Mediated Through the Opening of Stretch‐Activated K2P Channels , 2012, Cell reports.

[47]  Xiaodong Wang,et al.  Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase , 2012, Cell.

[48]  B. Goilav.  Apoptosis in polycystic kidney disease. , 2011, Biochimica et biophysica acta.

[49]  P. Juin,et al.  Serum-Nutrient Starvation Induces Cell Death Mediated by Bax and Puma That Is Counteracted by p21 and Unmasked by Bcl-xL Inhibition , 2011, PloS one.

[50]  B. Finlay,et al.  The Phosphoinositide-3-Kinase–Akt Signaling Pathway Is Important for Staphylococcus aureus Internalization by Endothelial Cells , 2011, Infection and Immunity.

[51]  Yi Tang,et al.  Phosphorylation of Tip60 by GSK-3 determines the induction of PUMA and apoptosis by p53. , 2011, Molecular cell.

[52]  L. Galluzzi,et al.  Mitotic catastrophe: a mechanism for avoiding genomic instability , 2011, Nature Reviews Molecular Cell Biology.

[53]  Q. Zhan,et al.  Cystogenesis in ARPKD results from increased apoptosis in collecting duct epithelial cells of Pkhd1 mutant kidneys. , 2011, Experimental cell research.

[54]  M. Caplan,et al.  The cell biology of polycystic kidney disease , 2010, The Journal of cell biology.

[55]  H. Kurahashi,et al.  Polycystic kidney disease in Han:SPRD Cy rats is associated with elevated expression and mislocalization of SamCystin. , 2010, American journal of physiology. Renal physiology.

[56]  R. Schwarzenbacher,et al.  Membrane Remodeling Induced by the Dynamin-Related Protein Drp1 Stimulates Bax Oligomerization , 2010, Cell.

[57]  C. Antignac,et al.  Nephrocystin-1 Forms a Complex with Polycystin-1 via a Polyproline Motif/SH3 Domain Interaction and Regulates the Apoptotic Response in Mammals , 2010, PloS one.

[58]  D. Green,et al.  The BCL-2 family reunion. , 2010, Molecular cell.

[59]  P. Vogt,et al.  Akt‐mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt , 2009, International journal of cancer.

[60]  Seamus J. Martin,et al.  Expression, purification and use of recombinant annexin V for the detection of apoptotic cells , 2009, Nature Protocols.

[61]  R. Nitschke,et al.  TRPP2 channels regulate apoptosis through the Ca2+ concentration in the endoplasmic reticulum , 2009, The EMBO journal.

[62]  P. Pandolfi,et al.  Polycystin-1 Regulates Extracellular Signal-Regulated Kinase-Dependent Phosphorylation of Tuberin To Control Cell Size through mTOR and Its Downstream Effectors S6K and 4EBP1 , 2009, Molecular and Cellular Biology.

[63]  C. Warren,et al.  Prevalence of smoking and other smoking-related behaviors reported by the Global Youth Tobacco Survey (GYTS) in Thailand , 2008, BMC public health.

[64]  A. Villunger,et al.  Bim and Bmf in tissue homeostasis and malignant disease , 2008, Oncogene.

[65]  Paola Chiarugi,et al.  Anoikis: a necessary death program for anchorage-dependent cells. , 2008, Biochemical pharmacology.

[66]  L. Cantley,et al.  Neutrophil gelatinase-associated lipocalin suppresses cyst growth by Pkd1 null cells in vitro and in vivo. , 2008, Kidney international.

[67]  M. Caplan,et al.  Polycystin-1 C-terminal tail associates with beta-catenin and inhibits canonical Wnt signaling. , 2008, Human molecular genetics.

[68]  H. Cantiello,et al.  Submembraneous microtubule cytoskeleton: interaction of TRPP2 with the cell cytoskeleton , 2008, The FEBS journal.

[69]  Cristina Montagna,et al.  Loss of polycystin-1 causes centrosome amplification and genomic instability. , 2008, Human molecular genetics.

[70]  P. Colman,et al.  To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions. , 2008, Molecular cell.

[71]  D. Rothenbacher,et al.  Prevalence of chronic kidney disease in population-based studies: Systematic review , 2008, BMC public health.

[72]  K. Mostov,et al.  Regulation of cell polarity during epithelial morphogenesis. , 2008, Current opinion in cell biology.

[73]  D. Green,et al.  Measuring apoptosis at the single cell level. , 2008, Methods.

[74]  Guido Kroemer,et al.  Autophagy in the Pathogenesis of Disease , 2008, Cell.

[75]  A. J. van der Beek,et al.  Design of a RCT evaluating the (cost-) effectiveness of a lifestyle intervention for male construction workers at risk for cardiovascular disease: The Health under Construction study , 2008, BMC public health.

[76]  E. Baehrecke,et al.  Growth Arrest and Autophagy Are Required for Salivary Gland Cell Degradation in Drosophila , 2007, Cell.

[77]  G. Germino,et al.  Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure , 2007, Proceedings of the National Academy of Sciences.

[78]  Alessandra Boletta,et al.  Polycystin-1 induces cell migration by regulating phosphatidylinositol 3-kinase-dependent cytoskeletal rearrangements and GSK3beta-dependent cell cell mechanical adhesion. , 2007, Molecular biology of the cell.

[79]  Laurie A. Smith,et al.  Long-lasting arrest of murine polycystic kidney disease with CDK inhibitor roscovitine , 2006, Nature.

[80]  P. Wilson,et al.  Stable Knockdown of Polycystin-1 Confers Integrin-α2β1–Mediated Anoikis Resistance , 2006 .

[81]  A. Strasser,et al.  Loss of PKD1 and loss of Bcl-2 elicit polycystic kidney disease through distinct mechanisms , 2006, Cell Death and Differentiation.

[82]  J. Domen,et al.  Renal failure causes early death of bcl-2 deficient mice , 2006, Mechanisms of Ageing and Development.

[83]  Masaaki Komatsu,et al.  Loss of autophagy in the central nervous system causes neurodegeneration in mice , 2006, Nature.

[84]  G. Germino,et al.  Polycystin-1 induces resistance to apoptosis through the phosphatidylinositol 3-kinase/Akt signaling pathway. , 2006, Journal of the American Society of Nephrology : JASN.

[85]  M. Bisceglia,et al.  Renal Cystic Diseases: A REVIEW , 2006, Advances in anatomic pathology.

[86]  Xiaogang Li,et al.  Polycystin-1 and polycystin-2 regulate the cell cycle through the helix–loop–helix inhibitor Id2 , 2005, Nature Cell Biology.

[87]  P. Clarke,et al.  Regulation of Caspase 9 through Phosphorylation by Protein Kinase C Zeta in Response to Hyperosmotic Stress , 2005, Molecular and Cellular Biology.

[88]  C. Edelstein.  What is the Role of Tubular Epithelial Cell Apoptosis in Polycystic Kidney Disease (PKD)? , 2005, Cell cycle.

[89]  Alexei Degterev,et al.  Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury , 2005, Nature chemical biology.

[90]  M. Hatano,et al.  Pkd1 regulates immortalized proliferation of renal tubular epithelial cells through p53 induction and JNK activation. , 2005, The Journal of clinical investigation.

[91]  Martijn H Breuning,et al.  Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease. , 2004, Human molecular genetics.

[92]  G. Germino,et al.  A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. , 2004, Journal of the American Society of Nephrology : JASN.

[93]  P. Wilson,et al.  Polycystic kidney disease: new understanding in the pathogenesis. , 2004, The international journal of biochemistry & cell biology.

[94]  Mark H Ellisman,et al.  Disruption of Mitochondrial Function during Apoptosis Is Mediated by Caspase Cleavage of the p75 Subunit of Complex I of the Electron Transport Chain , 2004, Cell.

[95]  Guido Kroemer,et al.  Cell death by mitotic catastrophe: a molecular definition , 2004, Oncogene.

[96]  Tullio Pozzan,et al.  Phosphorylation of BCL‐2 regulates ER Ca2+ homeostasis and apoptosis , 2004, The EMBO journal.

[97]  P. Wilson,et al.  Polycystic kidney disease. , 2004, The New England journal of medicine.

[98]  M. Mattson,et al.  Calcium orchestrates apoptosis , 2003, Nature Cell Biology.

[99]  L. Guay-Woodford.  Murine models of polycystic kidney disease: molecular and therapeutic insights. , 2003, American journal of physiology. Renal physiology.

[100]  L. Goldstein,et al.  Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[101]  G. Germino,et al.  Cleavage of polycystin-1 requires the receptor for egg jelly domain and is disrupted by human autosomal-dominant polycystic kidney disease 1-associated mutations , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[102]  Toshiyuki Obata,et al.  Akt Enhances Mdm2-mediated Ubiquitination and Degradation of p53* , 2002, The Journal of Biological Chemistry.

[103]  James P Calvet,et al.  Polycystin-1 Activation of c-Jun N-terminal Kinase and AP-1 Is Mediated by Heterotrimeric G Proteins* , 2002, The Journal of Biological Chemistry.

[104]  Alessandra Boletta,et al.  PKD1 Induces p21waf1 and Regulation of the Cell Cycle via Direct Activation of the JAK-STAT Signaling Pathway in a Process Requiring PKD2 , 2002, Cell.

[105]  V. D’Agati,et al.  c-myc-induced apoptosis in polycystic kidney disease is independent of FasL/Fas interaction. , 2002, Cancer research.

[106]  M. Lucia,et al.  Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease. , 2002, Kidney international.

[107]  G. Germino,et al.  Expression of PKD1 and PKD2 transcripts and proteins in human embryo and during normal kidney development. , 2002, The American journal of pathology.

[108]  S. Somlo,et al.  Polycystin-2 is an intracellular calcium release channel , 2002, Nature Cell Biology.

[109]  A. Strasser,et al.  Degenerative disorders caused by Bcl-2 deficiency prevented by loss of its BH3-only antagonist Bim. , 2001, Developmental cell.

[110]  K. Brindle,et al.  Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[111]  G. Germino,et al.  Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells. , 2000, Molecular cell.

[112]  C. Borner,et al.  Bcl-2 decreases the free Ca2+ concentration within the endoplasmic reticulum. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[113]  S. Somlo,et al.  Identification and Characterization of Polycystin-2, the PKD2 Gene Product* , 1999, The Journal of Biological Chemistry.

[114]  Thierry Arnould,et al.  The Polycystic Kidney Disease 1 Gene Product Modulates Wnt Signaling* , 1999, The Journal of Biological Chemistry.

[115]  G. Walz,et al.  The Polycystic Kidney Disease 1 Gene Product Mediates Protein Kinase C α-dependent and c-Jun N-terminal Kinase-dependent Activation of the Transcription Factor AP-1* , 1998, The Journal of Biological Chemistry.

[116]  V. D’Agati,et al.  C-MYC–induced Apoptosis in Polycystic Kidney Disease Is Bcl-2 and p53 Independent , 1997, The Journal of experimental medicine.

[117]  B. Weston,et al.  Polycystin expression during embryonic development of human kidney in adult tissues and ADPKD tissue , 1997, The Histochemical Journal.

[118]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[119]  K. Zerres,et al.  Enhanced apoptotic cell death of renal epithelial cells in mice lacking transcription factor AP-2beta. , 1997, Genes & development.

[120]  A. V. D. van den Ouweland,et al.  The Han:SPRD rat is not a genetic model of human autosomal dominant polycystic kidney disease type 1 , 1997, Laboratory animals.

[121]  C. Borner.  Diminished Cell Proliferation Associated with the Death-protective Activity of Bcl-2* , 1996, The Journal of Biological Chemistry.

[122]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[123]  D. Woo,et al.  Apoptosis and loss of renal tissue in polycystic kidney diseases. , 1995, The New England journal of medicine.

[124]  S. Korsmeyer,et al.  Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair , 1993, Cell.

[125]  V. Stewart,et al.  Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. , 1993, Science.

[126]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[127]  H. Puthalakath,et al.  BH3-Only Proteins in Health and Disease. , 2017, International review of cell and molecular biology.

[128]  C. Borner,et al.  SPATA 2 promotes CYLD activity and regulates TNF-induced NF-j B signaling and cell death , 2016 .

[129]  V. Torres,et al.  Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. , 2014, Journal of the American Society of Nephrology : JASN.

[130]  B. Hyman,et al.  Measuring caspase activity in vivo. , 2014, Methods in enzymology.

[131]  P. Wilson,et al.  Stable knockdown of polycystin-1 confers integrin-alpha2beta1-mediated anoikis resistance. , 2006, Journal of the American Society of Nephrology : JASN.

[132]  V. Torres,et al.  Autosomal dominant polycystic kidney disease. , 2003, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

[133]  P. Wilson.  mechanisms of disease Polycystic Kidney Disease , 2003 .

[134]  V. D’Agati,et al.  Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression. , 1998, The American journal of pathology.

[135]  S. Korsmeyer,et al.  Fulminant metanephric apoptosis and abnormal kidney development in bcl-2-deficient mice. , 1995, The American journal of physiology.